Everything Totally Explained


Ask & we'll explain, totally!
17-beta-hydroxysteroid dehydrogenase deficiency
Totally Explained


  NEW! All the latest news in the worlds of computer gaming, entertainment, the environment,  
finance, health, politics, science, stocks & shares, technology and much, much, more.  


    View this entry using RSS
   

Everything about 17-beta-hydroxysteroid Dehydrogenase Deficiency totally explained

17-beta-hydroxysteroid dehydrogenase deficiency-3 is a rare disorder of sexual development affecting testosterone biosynthesis, which can produce impaired virilization (traditionally termed male pseudohermaphroditism) of genetically male infants and children and excessive virilization of female adults.
   It is an autosomal recessive condition and is one of the few disorders of sexual development that can affect the primary and/or secondary sex characteristics of both males and females.

Prevalence

In the Netherlands, 17-beta-hydroxysteroid dehydrogenase deficiency is estimated to occur 1:147.000 newborns.

Clinical characteristics

17-beta-hydroxysteroid dehydrogenase deficiency-3 is clinically characterized by either ambiguous external genitalia or complete female external genitalia at birth; as a consequence of impaired male sexual differentiation in 46,XY individuals. Further investigations on ambiguous genitalia will eventually lead to findings of intersexuality. Severely impaired virilization (often complete absence of male sexual differentiation) can lead to development of female external genitalia. These children are raised as female, and their diagnosis is often discovered when there's absence of menarche (first menstruation) and when they begin to virilize during puberty (slowly become more like a man; deepening of the voice, acne, male musculature etc). At careful examination, testis can often be found in the inguinal channel.

Biochemistry

17-beta-hydroxysteroid dehydrogenase deficiency-3 is biochemically characterized by decreased levels of testosterone and increased levels of androstenedione as a result of the defect in conversion of androstenedione into testosterone. This leads to clinically important higher ratio of androstenedione to testosterone (A'dion/T) (see figure).

Genetics


   17-beta-hydroxysteroid dehydrogenase deficiency-3 is caused by gene mutations found in the 17Beta Hydroxysteroid dehydrogenase (17BHSD3). 17BHSD3 deficiency-3 is an autosomal recessive disorder.

Further Information

Get more info on '17-beta-hydroxysteroid Dehydrogenase Deficiency'.


External Link Exchanges

Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:

    <a href="http://17-beta-hydroxysteroid_dehydrogenase_deficiency.totallyexplained.com">17-beta-hydroxysteroid dehydrogenase deficiency Totally Explained</a>

Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
   As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned.



Copyright © 2007-8 totallyexplained.com | Licensed under the GNU Free Documentation License | Site Map
This article contains text from the Wikipedia article 17-beta-hydroxysteroid dehydrogenase deficiency (History) and is released under the GFDL | RSS Version